Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Deering

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|June 22, 2017
Supporting Change in Oncology Nursing Practice in KuwaitVeronica Nickerson, Jennifer Deering, Suha Alazmei
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 5, 2022
Getting back on track: a group psychoeducational intervention for patients and families living with head and neck cancerAllyson Mayo, Jerry Lam, Manjula Maganti, et al.
Clinical Pharmacology and Therapeutics|October 2, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 AntagonistsVictoria Gershuny, Qin Sun, Sarah J Schrieber, et al.
Clinical and Translational Science|November 30, 2025
Proteomic Identification of Plasma Biomarkers of Response to IL-5 Inhibitor Biologics in Healthy SubjectsLakshmi Manasa S Chekka, Deepti P Samarth, Kristina E Howard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|June 22, 2017
Supporting Change in Oncology Nursing Practice in KuwaitVeronica Nickerson, Jennifer Deering, Suha Alazmei
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 5, 2022
Getting back on track: a group psychoeducational intervention for patients and families living with head and neck cancerAllyson Mayo, Jerry Lam, Manjula Maganti, et al.
Clinical Pharmacology and Therapeutics|October 2, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 AntagonistsVictoria Gershuny, Qin Sun, Sarah J Schrieber, et al.
Clinical and Translational Science|November 30, 2025
Proteomic Identification of Plasma Biomarkers of Response to IL-5 Inhibitor Biologics in Healthy SubjectsLakshmi Manasa S Chekka, Deepti P Samarth, Kristina E Howard, et al.
Pageof 1